Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis
about
Antibodies to mutated citrullinated vimentin for diagnosing rheumatoid arthritis in anti-CCP-negative patients and for monitoring infliximab therapyEvidence of fibrinogen as a target of citrullination in IgM rheumatoid factor-positive polyarticular juvenile idiopathic arthritisThe serological diagnosis of rheumatoid arthritis: antibodies to citrullinated antigensPerinatal biomarkers in prematurity: early identification of neurologic injuryThe role of citrullinated protein antibodies in predicting erosive disease in rheumatoid arthritis: a systematic literature review and meta-analysisThe effect of targeted rheumatoid arthritis therapies on anti-citrullinated protein autoantibody levels and B cell responsesIncreased phosphorylation of vimentin in noninfiltrative meningiomasSynovial detection and autoantibody reactivity of processed citrullinated isoforms of vimentin in inflammatory arthritides.Recent advances in the understanding of renal inflammation and fibrosis in lupus nephritis.Coherent somatic mutation in autoimmune disease.Comparison of two assays to determine anti-citrullinated peptide antibodies in rheumatoid arthritis in relation to other chronic inflammatory rheumatic diseases: assaying anti-modified citrullinated vimentin antibodies adds value to second-generatioAberrant IgG galactosylation precedes disease onset, correlates with disease activity, and is prevalent in autoantibodies in rheumatoid arthritis.Immediate determination of ACPA and rheumatoid factor--a novel point of care test for detection of anti-MCV antibodies and rheumatoid factor using a lateral-flow immunoassayAntibodies against cyclic citrullinated peptides in infectious diseases--a systematic review.Role of anti-citrullinated protein antibodies in diagnosis and prognosis of rheumatoid arthritis.Anti-citrullinated protein antibodies and their clinical utility in rheumatoid arthritis.Diagnostic value of the anti-Sa antibody compared with the anti-cyclic citrullinated peptide antibody in rheumatoid arthritis.Old drugs, old problems: where do we stand in prediction of rheumatoid arthritis responsiveness to methotrexate and other synthetic DMARDs?Anticitrullinated protein antibody (ACPA) in rheumatoid arthritis: influence of an interaction between HLA-DRB1 shared epitope and a deletion polymorphism in glutathione S-transferase in a cross-sectional study.Vimentin is a dominant target of in situ humoral immunity in human lupus tubulointerstitial nephritisDiagnostic accuracy of anti-MCV and anti-CCP antibodies in rheumatoid arthritis: A meta-analysis.Vimentin filament organization and stress sensing depend on its single cysteine residue and zinc binding.Diagnostic performance of a new vimentin-derived ACPA (CCP high sensitive) in patients with rheumatoid arthritis.Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentinAn investigation of the added value of an ACPA multiplex assay in an early rheumatoid arthritis setting.Evaluation of anti-mutated citrullinated vimentin antibodies, anti-cyclic citrullinated Peptide antibodies and rheumatoid factor in omani patients with rheumatoid arthritisAnti-type II collagen antibodies are associated with early radiographic destruction in rheumatoid arthritis.In vitro eradication of citrullinated protein specific B-lymphocytes of rheumatoid arthritis patients by targeted bifunctional nanoparticles.Greater prevalence of seropositivity for anti-cyclic citrullinated peptide antibody in unaffected first-degree relatives in multicase rheumatoid arthritis-affected families.DNA methylome signature in rheumatoid arthritis.Regulation of DNA methylation in rheumatoid arthritis synoviocytes.Antibodies to mutated citrullinated vimentin and disease activity score in early arthritis: a cohort study.Higher levels of autoantibodies targeting mutated citrullinated vimentin in patients with psoriatic arthritis than in patients with psoriasis vulgarisA chronic model of arthritis supported by a strain-specific periarticular lymph node in BALB/c mice.Carbamylated vimentin represents a relevant autoantigen in Latin American (Cuban) rheumatoid arthritis patients.Unique correlation between mutated citrullinated vimentine IgG autoantibodies and markers of systemic inflammation in rheumatoid arthritis patientsIdentification of novel antiacetylated vimentin antibodies in patients with early inflammatory arthritisLong-lasting tissue inflammatory processes trigger autoimmune responses to extracellular matrix molecules.Role of anti-vimentin antibodies in allograft rejection.Citrullination in the periodontium--a possible link between periodontitis and rheumatoid arthritis.
P2860
Q21195370-5897AABF-0EF5-434A-B1CD-9434C0987EB9Q21245434-80C8DBC0-1208-4C1E-BBCD-1B51D8FCA3E3Q24646963-F8E2FD73-8641-4738-8D6D-FEE8EA668CF6Q26853539-216F93CC-0AE9-433E-8E42-042B1D2A211DQ26999006-FC03016A-19B6-4B7E-A085-1520BC148F3EQ27022645-8959AAFB-84CB-4FA1-B58C-48C802472476Q28748900-3115FE25-9DAA-46F7-BC38-F60E86866613Q33322989-413653E5-CE57-4357-894B-670BD941F405Q33806541-47727484-0E8A-4932-BC22-5586B2EEC305Q33837769-1767F0F3-0AA7-4B1B-A07F-456AE55EC5F5Q33849849-E2B131CB-4B8B-43EA-8CA6-84EF404785F7Q33986960-EFE60AA7-3BEE-42B2-803A-6DA2EF1AABAAQ34027640-8557E1C3-891E-4679-B85A-D830D663F91BQ34129802-80296EE0-42F5-4451-8BD2-BF9D7C4BC1E0Q34250833-6771D4FA-D173-4D94-B016-C95E01C33867Q34367709-3A809991-B54E-41CD-8CFF-4DF759351739Q34452744-5691653F-3E5D-442E-BFF0-0B70F76D2B02Q34559803-E2DD1B32-8C7D-4496-9CBD-1B40BE8A71F7Q34613982-505DD52A-F957-4B09-8241-1CECC5F1BB53Q35324023-5E186282-FC63-4BFA-AE58-191921C11876Q35674804-40CD1DB2-24CC-408D-9E7C-268329C88548Q35692691-2F9D6BA2-DBFE-4AF3-8A95-E16719AF7124Q35767209-6FA5380E-D8D5-4AE4-8863-4FF6B4C0CED2Q35913720-CB5FD555-9176-466B-A66D-6312D773F133Q36127049-6697D88C-D5A1-4043-887F-F6770968C58DQ36184783-E5D36299-7C4D-476B-9B23-E47550DFADBAQ36245913-C7AB3D14-F26B-494A-B9F9-8D6ECF9369C6Q36477500-980E4DBE-3B19-4047-B28A-7748F51C9BDAQ36528908-05DA1FCF-7A0D-4BF6-8147-02F3820A6139Q36546471-F6554A50-E51E-4977-B9BD-76EC22592C01Q36553359-71ABF625-A74C-4C85-A33F-3FA1E7A9089FQ36641506-B2DCF01A-3B39-4129-BBFE-466E2ECF0A4EQ36733774-E04D8069-E905-4226-8B61-2E702EEDEF30Q36815454-69049FFD-A842-4B78-9279-F03D8D2A209DQ36918405-EDA3610E-C721-4DBA-95A2-45A1290D35E4Q36946220-C0F28A71-385D-4A77-9E62-B80EA4174556Q36968767-DB6A32AB-F3A3-4BCE-8B9B-3F6DD87253FCQ37147938-8DBBC528-B356-4FB4-9674-4949E18C67F4Q37286553-33729E56-EE8A-4F91-A3B6-292778725C71Q37488177-BF93F465-CC20-4CAC-8112-F4F5F24B8895
P2860
Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis
description
2007 nî lūn-bûn
@nan
2007 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Mutation and citrullination mo ...... tigen for rheumatoid arthritis
@ast
Mutation and citrullination mo ...... tigen for rheumatoid arthritis
@en
Mutation and citrullination mo ...... tigen for rheumatoid arthritis
@nl
type
label
Mutation and citrullination mo ...... tigen for rheumatoid arthritis
@ast
Mutation and citrullination mo ...... tigen for rheumatoid arthritis
@en
Mutation and citrullination mo ...... tigen for rheumatoid arthritis
@nl
prefLabel
Mutation and citrullination mo ...... tigen for rheumatoid arthritis
@ast
Mutation and citrullination mo ...... tigen for rheumatoid arthritis
@en
Mutation and citrullination mo ...... tigen for rheumatoid arthritis
@nl
P2093
P2860
P3181
P356
P1476
Mutation and citrullination mo ...... tigen for rheumatoid arthritis
@en
P2093
Anke Gauliard
Eugen Feist
Gert Fredenhagen
Holger Bang
Kirsten Lüthke
Paul E Rudolph
Wigbert Berg
P2860
P304
P3181
P356
10.1002/ART.22817
P407
P577
2007-08-01T00:00:00Z